PPD10558

· Furiex Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PPD10558, covering 2011-12-22 to 2011-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) [Phase 2]

See pricing